|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 749-755.
Prepublished online as a Blood First Edition Paper on March 29, 2005; DOI 10.1182/blood-2004-10-4087.
Previous Article | Next Article 
Submitted October 22, 2004
Accepted December 3, 2004
Critical role of host  T cells in experimental acute graft-versus-host disease
Yoshinobu Maeda, Pavan Reddy, Kathleen P Lowler, Chen Liu, D K Bishop, and James L Ferrara*
Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, MI, USA
Department of Pathology, University of Florida College of Medicine, Gainesville, FL, USA
Department of General Surgery, University of Michigan Cancer Center, Ann Arbor, MI, USA
Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, MI, USA; Department of Pediatrics, University of Michigan Cancer Center, Ann Arbor, MI, USA
* Corresponding author; email: ferrara{at}umich.edu.
 T cells localize to target tissues of graft-versus-host disease (GVHD) and therefore we investigated the role of host  T cells in the pathogenesis of acute GVHD in several well-characterized allogeneic bone marrow transplantation (BMT) models. Depletion of host  T cells in wild type (wt) B6 recipients by administration of anti-TCR  monoclonal antibody reduced GVHD and  T cell deficient ( -/-) BMT recipients markedly improved survival compared to normal controls (63% vs. 10%, P< 0.001).  T cells were responsible for this difference because reconstitution of  -/- recipients with  T cells restored GVHD mortality.  -/- recipients showed decreased serum levels of TNF- , less GVHD histopathologic damage and reduced donor T cell expansion. Mechanistic analysis of this phenomenon demonstrated that dendritic cells (DCs) from  -/- recipients exhibited less allostimulatory capacity compared to wt DCs after irradiation. Normal DCs derived from BM caused greater allogeneic T cell proliferation when co-cultured with  Tcells than DCs co-cultured with medium alone. This enhancement did not depend on IFN- , TNF- or CD40 ligand but did depend on cell-cell contact. These data demonstrated that the host  T cells exacerbate GVHD by enhancing the allostimulatory capacity of host antigen presenting cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Host
 T cells: an innate bridge to the epithelial targets of GVHD?
- Geoffrey R. Hill
Blood 2005 106: 393-394.
[Full Text]
[PDF]
Related Letter in Blood Online:
-
Recipient
 T cells in graft-versus-host disease
- Britt E. Anderson, Warren D. Shlomchik, Mark J. Shlomchik, James L. M. Ferrara, and Pavan Reddy
Blood 2006 107: 3808-3809.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Flierl, D. Rittirsch, H. Gao, L. M. Hoesel, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, J. L. M. Ferrara, et al.
Adverse functions of IL-17A in experimental sepsis
FASEB J,
July 1, 2008;
22(7):
2198 - 2205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hochegger, T. Schatz, P. Eller, A. Tagwerker, D. Heininger, G. Mayer, and A. R. Rosenkranz
Role of {alpha}/beta and {gamma}/{delta} T cells in renal ischemia-reperfusion injury
Am J Physiol Renal Physiol,
September 1, 2007;
293(3):
F741 - F747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chakraverty and M. Sykes
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood,
July 1, 2007;
110(1):
9 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pabst, H. Schirutschke, G. Ehninger, M. Bornhauser, and U. Platzbecker
The Graft Content of Donor T Cells Expressing {gamma}{delta}TCR+ and CD4+foxp3+ Predicts the Risk of Acute Graft versus Host Disease after Transplantation of Allogeneic Peripheral Blood Stem Cells from Unrelated Donors
Clin. Cancer Res.,
May 15, 2007;
13(10):
2916 - 2922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rowe, T. Banovic, K. P. MacDonald, R. Kuns, A. L. Don, E. S. Morris, A. C. Burman, H. M. Bofinger, A. D. Clouston, and G. R. Hill
Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation
Blood,
October 1, 2006;
108(7):
2485 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Anderson, W. D. Shlomchik, M. J. Shlomchik, J. L. M. Ferrara, and P. Reddy
Recipient {gamma}{delta} T cells in graft-versus-host disease.
Blood,
May 1, 2006;
107(9):
3808 - 3809.
[Full Text]
[PDF]
|
 |
|
|
|